GAITHERSBURG, Md., Dec. 18 /PRNewswire/ -- Panacea Pharmaceuticals' lung cancer diagnostic test, LC Detect(SM), has been named one of Time Magazine's Ten Biggest Medical Breakthroughs of 2007 (Due to length of URL, please cut and paste into browser: http://www.time.com/time/specials/2007/top10/article/0,30583,1686204_1686252_1690390, 00.html) LC Detect(SM) is a simple blood test to facilitate the identification of lung cancer, even among individuals with early-stage disease. Panacea Laboratories, a division of Panacea Pharmaceuticals, is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). The blood sample can be ordered by any physician and sent to Panacea for testing; sample and shipping requirements are available at http://www.panacea-labs.com.
Lung cancer accounts for the highest number of cancer deaths worldwide,
in both men and women. An estimated 213,380 new cases of cancer involving
the lung or bronchus are expected in the U.S. in 2007, accounting for about
15 percent of total cancer diagnoses. An estimated 160,390 deaths,
accounting for about 29 percent of all cancer deaths, are expected to occur
in 2007. Since 1987, more women have died each year from lung cancer than
from breast cancer. Lung cancer was the third most common cancer for men
and the fifth most common cancer for women in Japan in 2000. The five-year
survival rate for lung cancer is only 15 percent. Survival rates for
individuals in whom lung cancer is detected at an early stage while it
remains localized are as high as 50 percent. Current screening and
detection methods rely on imaging modalities, primarily chest x-ray and CT
scanning. However, chest x-ray is not sufficiently sensitive and CT
scanning is expensive with only a moderate improvement in sensitivity.
Newer tests, suc
|SOURCE Panacea Pharmaceuticals|
Copyright©2007 PR Newswire.
All rights reserved